SK-OV-3 cells
Cat# C0017008
Size : OneFrozenvial
Disease:
Ovarian serous cystadenocarcinoma
Origin:
Derived from the ascitic fluid from a 64 year old caucasian female with an ovarian tumor. Forms moderately well-differentiated adenocarcinoma consistent with ovarian primary cells.
Species:
Homo sapiens, human Ovary: ascites Epithelial Adherent Hypodiploid to hypotetraploid Female, Caucasian, 64 years of age AddexBio-Formulated DMEM (C0003-03) + 10% FBS Subculture sub-confluent cultures (85%) at 1:2 to 1:6 ratio, using 0.25% (w/v) Trypsin- 0.53 mM EDTA solution. Culture at 5% CO2, 37°C. Complete growth culture medium supplemented with 7.5% (v/v) DMSO I Bacteria: Negative Yeast: Negative Mycoplasma: Negative HIV: Negative Hepatitis B: Negative HPV: Negative EBV: Negative CMV: Negative Amelogenin: X CSF1PO: 11 D13S317: 8,11 D16S539: 12 D5S818:11 D7S820: 13,14 THO1:9,9.3 TPOX: 8,11 vWA: 17,18 If use of this culture results in a scientific publication, it should be cited in the publication as: SK-OV-3 (AddexBio C0017008) Tissue:
Morphology:
Properties:
Cytogenic data:
Patient:
Medium:
Subculture:
Freezing Medium:
Biosafety Level:
Sterility:
Pathogens:
DNA Profile (STR):
Citation Format:
References for SK-OV-3 cells:
1. Morimoto H, Yonehara S, Bonavida B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 1993 Jun 1;53(11):2591-2596. PMID: 7684321